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Summary 
Backgrourd: Diabetes mellitus can induce a pattern of my- 
ocardial pathology known as specific diabetic cardiomyopa- 
thy, even if this is not clearly specified. 
Hvpothesis: The aim of our study was to evaluate the pres- 
ence of preclinical myocardial damage in insulin- and non-in- 
sulin-dependent diabetic patients and controls by assessment 
with Doppler echocardiography. 
Methods: Twenty insulin-dependent diabetic (IDDM) pa- 
tients, I0 non-insulin-dependent diabetic (NIDDM) patients, 
and 12 healthy individuals (C) as controls, matched for age, 
gender, and without overt cardiovascular disease, were as- 
sessed in this study. 
Results: Systolic function parameters presented normal val- 
ues in the three groups, with the exception of a slight reduction 
in ventricular volume indices in the NIDDM group. Diastolic 
function was clearly impaired in both groups of patients versus 
that in healthy controls. In particular, ventricular filling was 
impaired in the NIDDM compared with the IDDM patients, 
especially the peak early filling rate E (p<O.OOl). Moreover, 
in the IDDM group, the duration of diabetes (p<O.Ol) and gly- 
cosilated hemoglobin value (HbAlC, p<0.02) were higher 
than in the NIDDM group. Multiple regression analysis show- 
ed a significant inverse correlation between HbAlC and peak 
late filling rate A (R2 = 0.28) in both groups of patients and a 
direct correlation between velocity time integral E and age, 
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duration of diabetes, and HbAIC (R2 = 0.46). The two groups 
presented a small, homogeneous number of case5 with initial 
microangiopathy and borderline autonomic neuropathy, asso- 
ciated with microalbuminuria. Doppler echocardiography 
showed an early impairment of left ventricular tilling, as well 
as an early preclinical alteration of myocardial function in dia- 
betic patients, especially in the NIDDM group. 
Conclusion: These early signs of cardiomyopathy could 
constitute a predisposing condition toward the high cardiac 
morbidity and mortality rate in diabetic patients. 
Key words: diabetes mellitus, Doppler echocardiography, di- 
abetic cardiomyopathy, diastolic function 
Introduction 
The existence of a specific diabetic cardiomyopathy has 
been suggested to be partly involved in the development ofcar- 
diac failure in diabetic patients, as demonstrated by its high in- 
cidence in this population.l4 Isolated impairment of left ven- 
tricular (LV) function, such as a preclinical myocardial defect 
in diabetic patients without overt heart disease. has k e n  exten- 
sively discussed. In these diabetic patients, LV systolic func- 
tion was seen to be normal, while abnormal diastolic tilling 
was found also in relation to the duration of diabetes and the 
presence of microangiopathy and diabetic autonomic neuropa- 
thy. In young, stable, well-compensated patients, the evaluu- 
tion of LV systolic and, in particular, diastolic function showed 
quite contradictory These studies were largely car- 
ried out in patients with insulin-dependent diabetes rnellitus 
(IDDM), although a small number of reports on ventricular 
systolic and diastolic impairment have also been published on 
non-insulin-dependent diabetic (NIDDM) patients.’ ‘-I3 
We performed an analysis of LV function in two groups of 
IDDM and NIDDM patients and in a group of nondiabetic 
controls, all free of any cardiovasculardisease known to affect 
myocardial function. In this paper, we report our results con- 
cerning LV ventricular systolic and diastolic function, as ana- 
lyzed by Doppler echocardiographic examination. 
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Patients and Methods 
The study was carried out in 20 patients with IDDM (15 
men, 5 women, age 33-54 years), I0 patients with NIDDM (6 
men, 4 women, age 38-SO years), and a control (C) group of 
12 healthy individuals (7 men, 5 women, age 3249  years). 
All subjects gave informed consent. 
All patients in the IDDM and NIDDM groups and the con- 
trols were without overt heart disease, as shown by clinical 
history, physical examination, and electrocardiogram (ECG). 
There were no cardiovascular risk factors other than diabe- 
tes (i.e., smoking, high blood pressure, hypercholesterole- 
mia). Moderate signs of microdngiopathy at the observation 
of fundus oculii were observed in two patients in the IDDM 
group and in two patients in the NIDDM group, and there was 
no evidence of renal failure due to diabetic nephropathy. All 
patients were examined for the presence of microalbuminuria, 
an important parameter in the evaluation of renal function; 
only the patients with microangiopathy showed overt mi- 
croalbuminuria. 
The IDDM patients received no treatment other than in- 
sulin; the NIDDM patients were treated with hypoglycemic 
agents, except for three who were treated with diet alone. 
Body mass index (BMI) was similar in the three groups con- 
sidered; the diabetic patients did not present recent ketoacido- 
sis. A glycosylated hemoglobin (HbAlc) measurement was 
taken from all patients within IS days of Doppler echocardio- 
graphy examination with a high-pressure liquid chromatogra- 
phy (HPLC) assessment (normal range 4.5-6.2) (Table I). 
Autonomic neural function was assessed by heart rate re- 
sponse to the Valsalva maneuver, deep breathing, and stand- 
ing, and by blood pressure response to standing. l 4  None of the 
patients was subjected to an evaluation of insulin blood levels 
at Doppler echocardiographic examination. 
All patients were examined in the fasting state and without 
insulin treatment at about 10 A.M., after a 15-min rest period 
in the rccuinbent position. Each patient was given acomplete 
TAHIX I 
dent diabetic patients versus healthy controls (C) 
Clinical data in insulin-dependent and non-insulin-depen- 
IDDM NIDDM C 
Age (years) 41.4r8.9 44.7 F 5.4 40.5 k 7.0 
Maletl'emale 1515 614 715 
BMI 24.34 r 2.77 24.78 k 3.25 23.85 2 2.53 
HR (beatslmin) 71.22 10.8 68.0~9.7 73.1 2 10.5 
SBP(mmHg) 137.02 10.5 139.52 10.1 136.329.5 
DD (years) I 6 . 5 4 i  8.14 5.8024.1 3b 
HbAic 9.48 2 I .23 8.26 r I .20" 
DBP (mmHg) 83.5 k 6.9 85.5 r4 .9  85.5 k5.2 
"p <0.02. 
"p<0.001. 
Ahhrevinrions: IDDM = insulin-dependent diabetic, NIDDM = non- 
insulin-dependent diabetic, BMI = body mass index, HR =heart rate, 
SBP= systolic blood pressure, DBP= diastolic blood pressure, DD = 
duration of disease, HbAlc =glycosyIated hemoglobin. 
Doppler echocardiographic examination by two expert ob- 
servers, who were totally blinded as to the patients' conditions. 
An ATL Apogee CX ultrasonograph device with 3.5 MHz, 
Doppler pulsed wave (PW) and continuous wave, and color 
PW transducer was used in the examination. Left ventricular 
function, ventricular and atrial diameter, wall thickness, and 
chamber volume were measured according to the recomnien- 
dations of the American Society of Echocardiography.l' 
Doppler PW analysis of LV diastolic filling was performed 
with apical four-chamber views and with sample volume at 
the tips of the mitral leaflets in the position providing the best 
color-flow projection. Three cardiac cycles were averaged for 
the following measurements: peak early filling rate (E), peak 
late filling rate (A), earlyhte (HA) ratio, and velocity time in- 
tegral of both E (E-VTI) and A (A-VTI). Isovolumetric relax- 
ation time was assessed with the sample volume in  an interme- 
diate position between mitral and aortic flow signal; moreover, 
the ratio between pre-ejection period and LV ejection time 
(PEPLVET) was calculated. In all patients, a 12-lead ECG 
was recorded, with no pathologic findings. 
The results were expressed as mean k standard deviation. 
Student's r-test for impaired data with a level of significance of 
5% was used for testing differences between groups. Variance 
analysis (ANOVA test) was used when appropriate, and any 
relationships between the parameters were tested with multi- 
ple regression analysis. 
Results 
All IDDM patients, NIDDM patients, and controls, 
matched for age, gender, and BMI, presented a normal scinti- 
graphic examination, with regular blood pressure, heart rate. 
and BMI (Table I). Most patients belonging to the IDDM and 
NIDDM groups had cardiovascular mtonomic responses in 
the normal range; a baseline abnormal response was observed 
in seven IDDM and four NIDDM patients for only one of the 
four types of programmed tests (Valsalva maneuver and deep 
breathing). The duration of diabetes was longer in the IDDM 
than in the NIDDM patients, and the HbAIc values were 
higher in the IDDM patients. 
Ventricular ejection fraction, interventricular septum, poste- 
rior wall thickness, left atrial diameter, end-systolic volume in- 
dex, and cardiac index were homogeneous in the three groups 
(Table 11). End-diastolic volume index was significantly dif- 
ferent between the NIDDM patients and the controls, while the 
IDDM group, as far as homogeneity is concerned, was in he- 
tween the aforementioned two groups. The same results were 
obtained for LV fractional shortening and for the PEPLVET 
ratio; in the IDDM group, the homogeneity of these two pi- 
rameters was in between the NIDDM and C groups (Table 11). 
Analysis of LV filling clearly showed differences between 
both groups of diabetic patients and controls (Table HI). 
Emphasizing the presence of an impaired diastolic function, 
peak early filling rate E was lower and peak late filling rate A 
was higher in the IDDM and NIDDM patients versus the con- 
trols, with a reduction in the EYA ratio; the values were similar 
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TABLE I1 
controls (C). Variance analysis among the three groups. 
Echocardiographic parameters of systolic function in insulin-dependent and non-insulin-dependent diabetic patients versus healthy 
IDDM NIDDM C Homogeneity ofthe groups 
EF (%) 63.42 c 6.5 1 64.70k7.85 62.95 f 4.82 NIDDM = IDDM = C 
LVFS (%) 33.72 +- 5.98 30.39 2 3.23 36.76 f 6.19 NIDDM # C; IDDM in between 
IVS (mm) 9.30 f 1.89 9.80f 1.65 9.05 2 1.27 NIDDM = IDDM = C 
PW (mmj 9.64f 1.34 9.40 f 1.45 8.92f 1.18 NIDDM = IDDM = C 
EDVI (ml) 54.9 f 9.0 49.4 f 6.1 54. I f 10.4 NIDDM # C: IDDM in between 
ESVI (ml) 19.9 f 4.6 17.4 24.5 21.723.7 NIDDM = IDDM = C 
SV (ml) 63.9 f 13.8 59.0 f 8.4 62.3 f 19.4 NIDDM = IDDM = C 
CI (1) 2.44 f 0.6 I 2.15 f 0.25 2.68 2 0.48 NIDDM = IDDM = C 
LAD (mm) 34.6 f 3.9 34.8 f 2.8 33.4 f 1.7 NIDDM = IDDM = C 
PEPLVET 0.385 0.083 0.447 f 0.1 I8 0.3 18 f 0.06 1 NIDDM #C; IDDM in between 
the twogroups(F= 3.h;p=0..036) 
the two groups (F= 4.8: p = 0.014) 
the two groups (F = 5.9; p = 0.005) 
ADhrrviorhis: IDDM = insulin-dependent diabetic, NIDDM = non-insulin-dependent diabetic, C =controls, EF = ejection fraction. LVFS = left 
ventricular fractional shortening, IVS = interventricular septum, PW = posterior wall thickness, EDVI = end-diastolic volume index. ESVI =end- 
systolic volume index, SV = stroke volume, CI = cardiac index, LAD = left atrial diameter, PEP/LVET= pre-ejection period/left ventricular ejec- 
tion time. # =non-homogeneous, ==homogeneous. 
regarding E-VTI, A-VTI, and EIA VTI. Therefore, the two 
groups of diabetic patients presented different values as to 
peak early filling rate E, E-VTI, and A-VTI, with a more pro- 
nounced diastolic impairment in the NIDDM group. 
In the NIDDM group, Doppler echocardiography findings 
for diastolic function were more strongly impaired than in the 
IDDM group, although significant differences were observed 
only for E, E-VTI, and A-VTI. Furthermore, IVRT was longer 
in diabetic patients, both IDDM and NIDDM, compared with 
controls (Table ITI). 
The relationship between Doppler echocardiographic pa- 
rameters and clinical data was tested. Multiple regression anal- 
ysis showed a negative correlation between HbA I C  and peak 
late filling rate A (R2 = 0.28), and a positive correlation be- 
tween E-VTI and age, duration of diabetes, and HbAlc. re- 
spectively (R2 = 0.48; p = 0.054; p = 0.0 1 ; p = 0.04). 
Discussion 
The impairment of LV function in diabetes has been dis- 
cussed in recent years using different data for defining the ex- 
istence of a specific card iorny~pathy .~ ,~  In selected groups of 
patients without overt cardiovascular disease, a preclinical ini- 
TABLE 111 
(C). Variance analysis among the three groups. 
Echocardiographic parameters of diastolic function in insulin-dependent and non-insulin-dependent diabetic patients versus controls 
IDDM NIDDM C Homogeneity of the groups 
E (ins) 0.825 f0.144 0.688 f 0.1 11 0.99 1 f 0.073 NIDDM # IDDM # C 
(F= 17.5; p<0.001) 
A (ms) 0.623 f 0.0995 0.660 f 0.176 0.478 f 0.089 NIDDM = IDDM. both # versus C 
(F = 7.96; p = 0.001 3) 
JYA 1.342 f 0.399 1.112 2 0.355 2.1 10f0.337 NIDDM = IDDM, both # versus C 
(F= 27.3: p<O.(X)I ) 
E-VTI 12.05 f 2.72 9.06 c 1.7 1 16.58 f 1.56 NIDDM # IDDM, # C 
(F= 149.1 ; p <0.001) 
A-VTI 6.40 +- 1.60 6.80 f 2.09 4.91 f 1.24 NIDDM = C, both # versus IDDM 
(F=42.7: p<O.001 ) 
WA-VTI 2.014f0.739 1.501 k0.395 3.588 f 1.009 NIDDM = IDDM, both # versus C 
(F= 26.3; p<O.OOI ) 
IVRT (ms) 87.50 f 2 1.72 102.002 19.32 71.91 f 16.55 NIDDM = IDDM, both # versus C 
(F= 8.5 1 ; p<O.001) 
Ahhrrviationc: E = peak early filling rate, A = peak late filling rate, E-VTI = velocity time integral E, A-VTI = velocity time integral A. IVRT = 
iwvolumetric relaxation time. Other abbreviations as in Table 11. 
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pairment of cardiovascular function can be assessed by nonin- 
vasive techniques, as shown in previous studie~.~-'~, l6 Systol- 
ic ventricular performance usually is regular;6>10, 17 the fact 
that it was occasionally impaired during ergometric stress was 
due to different ventricular load conditions rather than to truly 
impaired ventricular contractility.6 Only in our NIDDM pa- 
tients was it possible to observe a slight decrease in volumetric 
indices versus the controls. Left ventricular fractional shorten- 
ing and end-diastolic volume index were impaired in diabetic 
patients, especially in the NIDDM group. 
The most accurate and earliest markers of an impaired ven- 
tricular function likely to progress toward cardiac insufficien- 
cy is diastolic dysfunction, analyzed using noninvasive tech- 
niques.'. s. 13, I 8  In our study, both IDDM and NIDDM 
patients showed an isolated impairment of ventricular filling, 
without clear signs of cardiovascular involvement. In the 
IDDM patients, a finding of diastolic abnormality is quite con- 
troversial; furthermore, in one of our previous studies, which 
involved a group of treated and well-compensated IDDM pa- 
tients and in which radionuclide angiography was used,I9 a 
normal ventricular filling rate was reported. 
Diastolic function appeared clearly impaired in both the 
IDDM and NIDDM groups, matched for age, gender, and 
BMI, with a more pronounced impairment in the NIDDM pa- 
tients. A decrease in peak early filling rate E associated with in- 
creased peak late filling rate A and prolonged IVRT was seen 
in both groups of patients, but was more marked in the NID- 
DM group. Besides, E-VTI showed a significant decrease and 
A-VTI an increase in diabetic patients; both parameters were 
more altered in NIDDM than in IDDM patients. Despite fea- 
turing a more pronounced diastolic abnormality, the NIDDM 
group had a shorter clinically recognized duration of diabetes 
and lower HbAlc values compared with the IDDM patients, 
but obviously the vascular and myocardial damage started in 
an indefinable prediabetic stage?O 
It can be assumed that IDDM patients are quite well identi- 
fied from diabetes mellitus onset. Clinical features appeared 
in IDDM as soon Langehrans' islets are damaged by viral or 
autoimmune events. Therefore, in NIDDM an overt clinical 
feature appeared slowly. Vascular and myocardial damage 
started before the dysmetabolic events become clear, while 
hyperinsulinemia, microalbuminuria, advanced glycosylated 
end products, and lipidic abnormalities could lead to a reduc- 
tion in ventricular compliance. A comparison between the 
two diabetic groups indicates no difference in the incidence of 
microangiopathic complications and/or autonomic neuropa- 
thy; in addition, microangiopathy or autonomic neuropathy 
do not seem to induce a parametric impairment of ventricular 
function prominently;6 otherwise, these clinical features pre- 
sented a weak correlation with ventricular dysfunction. 
The mechanism by which diabetic disease might induce 
diastolic dysfunction remains to be clarified. The histologic 
findings typical of diabetes are well known, especially in the 
vascular and myocardial structures, as is the possible neuro- 
humoral mechanism that may induce cardiovascular dys- 
function.', 22 A possible explanation of diastolic impair- 
ment might be that it is the consequence of an increased LV 
masshody surface area in NIDDM patients, even if this was 
ruled out in our patients. The mechanism causing LV hyper- 
trophy is still not clear; in the absence of high blood pressure 
levels, such as in our patients, a different process might bc 
involved: as an example, hyperinsulinemia or, alternatively. 
associated metabolic abnormalities may lead to lower LV 
compliance'. 23. 24 which, if longstanding, may enhance LV 
mass.25 Therefore, a development of ventricular muscle stiff- 
ness due to elevated tissue calcium levels, associated with a 
defective sarcoplasmic reticular calcium-ATPase and a redis- 
tribution of myosin isoenzymes from the most active V I form 
to the least active V3 form, was experimentally demonstrated 
in NIDDM patients who have pathologic mechanisms that 
are quite different from IDDM.24 Vascular wall changes and 
increased LV mass, typically associated with generalized car- 
diovascular metabolic disease?6 might be the primary conse- 
quence of NIDDM. 
Conclusion 
An impairment of left ventricular diastolic filling as an ear- 
ly sign of ventriculardysfunction was observed to be prevalent 
in NIDDM patients compared with IDDM patients, none of 
whom displayed evidence of any cardiovascular disease. Re- 
duced diastolic function was not rebated to any sign of auto- 
nomic neuropathy or to metabolic control, duration of diabe- 
tes, or presence of microangiopathy. Moreover, these abnor- 
malities were not well represented in our patients. 
Our findings erased some important considerations in the 
field of therapeutic approach to diabetes. Patients need to be 
treated in the early stage of diabetes to prevent the develop- 
ment of diabetic cardiomyopathy. Diabetic heart is at increas- 
ed risk of damage from both macrovascular and microvascu- 
larinsults; the metabolic perturbations of diabetes alone result 
in myocardial dysfunction. With recognition and control of 
dysmetabolic state (e.g., hyperinsulinemia) in diabetic pa- 
tients, the development of diabetic heart disease may be re- 
tarded. If good control of dysmetabolic state was not achieved 
early, it is important to consider diastolic abnormality as a pos- 
sible risk factor worsening the prognosis of diabetic patients, 
especially those with NIDDM, even without overt cardiovns- 
cular features. 
The observation of an isolated impairment of diastolic 
function that may be detected in other cardiovascular diseases 
(i.e., hypertension, coronary artery disease, cardiomyopath y ), 
might be considered to beone of the factors inducing a higher 
incidence of cardiac morbidity and mortality among diabetic 
patients, particularly those how are non-insulin-dependent. 
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